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Abstract A large number of antibiotics and other industrially
important microbial secondary metabolites are synthesized by
polyketide synthases (PKSs) and nonribosomal peptide syn-
thetases (NRPSs). These multienzymatic complexes provide
an enormous flexibility in formation of diverse chemical
structures from simple substrates, such as carboxylic acids
and amino acids. Modular PKSs and NRPSs, often referred
to as megasynthases, have brought about a special interest due
to the colinearity between enzymatic domains in the proteins
working as an “assembly line” and the chain elongation and
modification steps. Extensive efforts toward modified com-
pound biosynthesis by changing organization of PKS and
NRPS domains in a combinatorial manner laid good grounds
for rational design of new structures and their controllable
biosynthesis as proposed by the synthetic biology approach.
Despite undeniable progress made in this field, the yield of
such “unnatural” natural products is often not satisfactory.
Here, we focus on type II thioesterases (TEIIs)—discrete
hydrolytic enzymes often encoded within PKS and NRPS
gene clusters which can be used to enhance product yield.
We review diverse roles of TEIIs (removal of aberrant resi-
dues blocking the megasynthase, participation in substrate
selection, intermediate, and product release) and discuss their
application in new biosynthetic systems utilizing PKS and
NRPS parts.
Keywords Type II thioesterase . Polyketide synthase .
Nonribosomal peptide synthetase . PKS . NRPS . Synthetic
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Introduction
Microorganisms have been long exploited for their ability to
produce antibiotics and a variety of other compounds of
medical and industrial importance. The progress in sequenc-
ing genomes and metagenomes made in the last decade re-
vealed the enormous potential for drug discovery by genome
mining (Nett et al. 2009; Gao et al. 2010; Boddy 2014). Many
species of actinomycetes have more than 20 gene clusters for
secondary metabolites, out of which only a few products are
known. The ways to get access to the new compounds include
heterologous expression of whole gene clusters (Gao et al.
2010; Li and Neubauer 2014) and also construction of mutat-
ed or hybrid enzymatic complexes for production of modified
structures (Baltz 2009; Olano et al. 2009a; Reeves and
Rodriguez 2009). Synthetic biology has developed new con-
cepts, such as “plug-and-play” engineering of predictable and
controllable systems out of defined parts (biobricks) and
“refactoring”—uncoupling them from native regulatory ele-
ments. Application of these approaches to biosynthesis of new
bioactive compounds has become realistic with technological
advances in de novo synthesis of hundred-kilobase long
stretches of DNA covering whole gene clusters (Cummings
et al. 2014; Yamanaka et al. 2014; Poust et al. 2014).
Although numerous examples of successful application of
the above strategies for the production of “unnatural” natural
compounds are available, obtaining high efficiency of such
artificial systems remains a challenge (Li and Neubauer 2014;
Poust et al. 2014). Here, we focus on an interesting class of
enzymes—type II thioesterases (TEIIs) coded within
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secondary metabolite gene clusters—which may be used to
improve product yield.
Modular polyketide synthases (PKSs) and nonribosomal
peptide synthetases (NRPSs) are particularly well suited for
combinatorial approach (Koglin and Walsh 2009; Reeves and
Rodriguez 2009). Both types of megasynthases remind as-
sembly lines where each cycle of chain elongation is per-
formed by a dedicated module made of covalently linked
enzymatic domains. All substrates and intermediates are
bound to the enzyme by a thioester linkage with a 4′-
phosphopantetheine (4′PP) arm of an acyl carrier protein
(ACP) domain in a PKS or peptidyl carrier protein (PCP)
domain in an NRPS. A thioesterase domain (type I
thioesterase (TEI)) is usually located at the C-terminus of the
last module and is responsible for the release of the full-length
chain by hydrolysis and often macrolactonization (Staunton
and Weissman 2001). In some cases, C-terminal reductase
domains are found in place of TEI, and their role in reductive
product release was shown or hypothesized (Gomez-
Escribano et al. 2012 and references therein). Several exam-
ples of chain release by discrete hydrolytic enzymes were also
described (Oliynyk et al. 2003; Liu et al. 2006, 2008; Xu et al.
2013; Zabala et al. 2014).
Many PKS and NRPS gene clusters contain genes for
TEIIs—discrete, 25–29-kDa proteins belonging to the α/β
hydrolase family which hydrolyze residues attached by
thioester bonds to 4′PP arms of acyl or PCPs. They are called
“type II” to stress the fact that they are not covalently bound to
the multienzyme, as opposed to TE domains (TEIs). TEIIs are
in most cases not essential for the synthesis of the correspond-
ing synthase product but play an important role in maintaining
the efficiency of the assembly line. In this article, the roles of
TEIIs involved in polyketide and nonribosomal peptide bio-
synthesis, are reviewed and the implications for
combinatorial/synthetic biology approaches are discussed.
Functions of TEIIs
TEIIs were first identified in some vertebrate fatty acid syn-
thase (FAS) complexes, where they play a role of alternative
chain terminating enzymes. FAS TEIIs hydrolyze thioesters of
shorter carbon chains (C8, C10, and C12) than the main
product—palmitic acid (C16)—released by the TEI domain
of FAS (Libertini and Smith 1978; Smith 1994).
Gene disruption experiments and studies of the catalytic
activity of TEII proteins against synthetic substrates showed
that in PKS and NRPS systems, these enzymes have a correc-
tive (editing) role, removing undesirable substrates and non-
reactivemoieties that block the NRPS and PKS. They can also
take part in the selection of starter units to be incorporated by
the synthases. In some cases, TEIIs are responsible for the
release of intermediates or final products (Fig. 1).
Synthetic substrates used to examine the activity of TEIIs
in vitro include derivatives of coenzyme A (CoA), p-nitro-
phenyl esters (p-NP), and thioesters of N-acetylcysteamine
(NAC) which allow spectrophotometric measurement of the
hydrolysis progress. NAC is a structural analog of
phosphopantetheine. Another group of substrates more close-
ly resembling the natural systems are isolated ACP (PCP)
domains or even entire PKS (NRPS) modules with different
polyketide/peptide chains and short residues attached to 4′PP
(Table 1).
Individual thioesterases differ significantly in their sub-
strate specificities and activities. Exploring the mechanisms
of action and kinetic parameters of TEIIs is important from the
point of view of potential practical applications of these
enzymes.
Removal of nonreactive acyl residues
Origins of acyl residues blocking the megasynthases
Biosynthesis of polyketides involves repeated cycles of con-
densation and reduction of short carboxylic acids in a manner
similar to fatty acid biosynthesis (Staunton and Weissman
2001). The first step of each biosynthetic cycle is a
decarboxylative condensation of a starter unit or the growing
chain from the previous module with a dicarboxylic extender
unit (in most cases, malonyl or methylmalonyl residue) at-
tached to the ACP via a thioester bond with 4′PP (Fig. 1a).
After reduction of the newly generated β-carbonyl group
(depending on the presence of reducing domains in a given
module), the chain is transferred to the subsequent module for
Fig. 1 Roles of type II thioesterases (TEIIs) associated with polyketide
synthases and nonribosomal peptide synthetases.Wavy line represents 4′-
phosphopantetheine (4′PP). KS ketosynthase, AT acyltransferase, ACP
acyl carrier protein, PCP peptidyl carrier protein. a Normal polyketide
chain elongation starts with a decarboxylative condensation catalyzed by
the KS domain. Incorrect decarboxylation of an extender unit without
condensation gives rise to an acyl residue attached to the ACP. Editing
TEII hydrolyzes the acyl residue and leaves the ACP free to accept a new,
dicarboxylated extender unit transferred by the AT domain. b ACP and
PCP domains are primed with a cofactor—4′PP—which is transferred by
a 4′PP transferase from coenzyme A (CoA). 4′PP transferases can also
accept acyl-CoA as a substrate and misprime carrier domains with acyl-4′
PP, thus making the attachment site inaccessible for an extender unit.
Editing TEII hydrolyzes the acyl residue and leaves the carrier domain
free to accept a correct substrate. c TEII influences the choice of the starter
unit by specific hydrolysis of some residues attached to the ACP of the
loading module. The residue which is not cleaved becomes a starting unit
for the polyketide chain. d Promiscuous TEIIs can remove amino acids
and polyketide synthesis intermediates, including correct dicarboxylated
extender units, if they are not readily processed by downstream domains.
e TEIIs specific for certain moieties which are required for the construc-
tion of the full structure of the metabolite release them from specific
carriers to make them available for the next biosynthetic step. Some TEIIs
release complete PKS/NRPS products from the multienzyme
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the next elongation cycle. Occasionally, decarboxylation of
extender units (mostly malonyl, methylmalonyl, and
ethylmalonyl) occurs without condensation. Products of such
aberrant decarboxylation (acetyl, propionyl, and butyryl resi-
dues, respectively) remain covalently attached to the ACP and
block the assembly line (Fig. 1a) (Heathcote et al. 2001).
In the process of nonribosomal peptide synthesis, extender
units are amino acids, and decarboxylation does not take place
here. Schwarzer et al. (2002) identified a different mechanism
of blocking NRPSs by nonreactive acyl residues. To obtain
the activity, the PCP domain must have a covalently attached
4′PP. 4′PP transferase is responsible for priming the PCP
domain with the cofactor. The source of 4′PP for the transfer-
ase is CoA, but the enzyme can also use different acylated
derivatives of CoA (Fig. 1b) (Dall’Aglio et al. 2011). Indeed,
it is often the case, since most of the CoAmolecules in the cell
are in the acylated form (Vallari et al. 1987). In the case of
joining acyl-4′PP to PCP domain (mispriming), the binding
site of amino acids and peptides is blocked, and this results in
the inactivation of the NRPS complex prior to the first round
of peptide synthesis. The acyl residue must be removed before
the PCP domain can fulfill its function.
ACP domains of PKSs, similarly to the NRPS PCP do-
mains, require the 4′PP cofactor and are turned to holoenzyme
form by the respective 4′PP transferases. It is very likely that,
in addition to erroneous decarboxylation of extender units,
mispriming of ACP with acyl-4′PP results in blocking of the
PKS with nonreactive residues (Pfeifer et al. 2002).
TEIIs with editing function
Modular megasynthases are usually built of several high
molecular mass proteins (several hundreds of kilodaltons),
and their synthesis and degradation are a significant effort
for the cell. Clearly, restoring the performance of NRPSs
and PKSs blocked by nonreactive residues would help to save
resources. TEII is an important element of such a mechanism.
As shown by biochemical studies, TEIIs hydrolyze acyl res-
idues which may arise from aberrant decarboxylation of ex-
tender units or from mispriming of carrier domains with acyl-
4′PP (Fig. 1a, b, Table 1) (Heathcote et al. 2001; Kim et al
2002; Schwarzer et al. 2002; Yeh et al. 2004; Zhou et al. 2008;
Kotowska et al 2009).
It was shown that TEII (TylO) from tylosin synthase of
Streptomyces fradiae hydrolyzes all three residues (acetyl,
propionyl, and butyryl) that can be formed by aberrant decar-
boxylation of extender units incorporated by tylosin synthase
(Table 1) (Heathcote et al. 2001). These observations are
consistent with the results of the experiment, where inactiva-
tion of tylO gene reduced polyketide production to about 10–
15 % of the normal level. Complementation of the mutation
with a copy of tylO gene restored wild-type production level
of polyketide (Butler et al. 1999). TEIIs from other PKSs are
also capable of improving performance of a PKS lacking its
own TEII. Complementation of the tylO mutation with nmbB
gene from narbomycin synthase of Streptomyces narbonensis
(Butler et al. 1999) and scoT gene from Cpk PKS of Strepto-
myces coelicolor A3(2) (Kotowska et al. 2002) increased
polyketide production to, respectively, 35–40 and 48 % of
the wild-type strain.
Deletion of rifR gene encoding TEII from rifamycin B
hybrid PKS/NRPS of Amycolatopsis mediterranei lowered
production of this compound to 40–60 % of normal levels
(Doi-Katayama et al. 2000). RifR thioesterase has broad sub-
strate specificity, hydrolyzing short, medium, and branched
chain substrates (Table 1). It preferentially hydrolyzes
decarboxylated acyl thioesters over natural (carboxylated)
extender units, which is consistent with its editing role in
removing blocking residues (Claxton et al. 2009).
Editing role of FscTE TEII associated with a modular PKS
synthesizing FR008/candicidin was also confirmed by genetic
and biochemical experiments (Zhou et al. 2008). TEII gene
deletion reduced polyketide production by 90 %, which was
restored by complementation with both native fscTE and
heterologous tylO genes. Furthermore, it was shown that
TEIIs originating from NRPS systems (tyrocidine and
surfactin synthetases) were not able to complement the fscTE
deletion (Zhou et al. 2008), reflecting their ability to distin-
guish between different ACP and PCP domains (Table 1)
(Schwarzer et al. 2002; Yeh et al. 2004).
Hydrolytic activity of the recombinant TEIIsrf protein from
surfactin synthetase toward acetyl group linked to the isolated
PCP domain is in accordance with the proposed function of
the TEII as a scavenger of acyl residues blocking the NRPS
(Table 1) (Schwarzer et al. 2002). Deletion of a gene encoding
TEIIsrf led to decrease of production by 84 % (Schneider and
Marahiel 1998).
Similarly, ybtT thioesterase gene deletion strongly reduced
the production of yersiniabactin siderophore by Yersinia
pestis. Geoffroy et al. (2000) and Miller et al. (2010) reported
that deletion mutant produced less than 6 % and approx. 25 %
of wild-type level, respectively. On the other hand, synthesis
of yersiniabactin in vitro was achieved using four biosynthet-
ic proteins, without TEII. Addition of YbtT thioesterase to the
reaction mixture did not increase the biosynthesis rate (Miller
et al. 2002). However, in the in vitro experiment, only
necessary precursors were present. It is likely that in vivo,
aberrant substrates interfere with the normal process and the
editing thiesterase is needed to remove them. Successful het-
erologous production of yersiniabactin was obtained when the
hybrid PKS/NRPS was expressed in Escherichia coli. Al-
though the presence of TEII was found not to be necessary
in this host, yersiniabactin production increased 2.5 times
upon expression of ybtT (Pfeifer et al. 2003).
Surprisingly, inactivation of ScoT thioesterase from Cpk
synthase which had been shown earlier to act as an editing
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Table 1 Enzymatic activity of type II thioesterases







TylO, tylosin cluster of Streptomyces fradiae (PKS) Acetyl-NAC 2.5 ND ND Heathcote et al. 2001
Propionyl-NAC 12.9 29.2 37.9
Butyryl-NAC 6.5 11.0 28.2
Pentanoate-NAC 1.7 ND ND
Diketidea-NAC 0.9 ND ND
Acetyl-p-NP 83 ND ND
Propionyl-p-NP 439 ND ND
Butyryl-p-NP 306 ND ND
Pentanoate-p-NP 284 ND ND
Triketideb-p-NP 39 ND ND
Acetyl-NAC 5.8 14.8 42.8 Zhou et al. 2008
Propionyl-NAC 10.9 23.2 35.6
FscTE, FR-008/candicidin cluster of Streptomyces sp.
strain FR-008 (PKS)
Acetyl-NAC 35.7 71.6 33.4 Zhou et al. 2008
Propionyl-NAC 56.9 109.2 32.0
ScoT, coelimycin cluster of Streptomyces coelicolor
A3(2) (PKS)
Acetyl-NAC 33 109 56 Kotowska et al. 2009
Propionyl-NAC 221 450 34
Butyryl-NAC 17 54 52
Acetyl-p-NP 788 ND ND
Propionyl-p-NP 3567 ND ND
Butyryl-p-NP 485 ND ND
PikAV, pikromycin cluster of Streptomyces
venezuelae (PKS)
Acetyl-ATLACPL 4.9 ND ND Kim et al. 2002
Propionyl-ATLACPL 15.8 ND ND
Butyryl-ATLACPL 17.5 ND ND
Malonyl-ATLACPL 3.9 ND ND
Methylmalonyl-ATLACPL 3.3 ND ND
Methylmalonyl-PikAIII 2.9 ND ND
NanE, nanchangmycin cluster of Streptomyces
nanchangensis NS3226 (PKS)
Nanchangmycin-NAC 2.5 0.0036 0.024 Liu et al. 2008
Nanchangmycin aglycone-NAC 0.15 0.0020 0.220
Monensin-NAC 0.070 0.00115 0.270
Salinomycin-NAC − − −
Diketidec-NAC 0.080 0.210 44
Ketodiketided-NAC 1.35 5.2 64




TycF, tyrocidine cluster of Bacillus brevis (NRPS) Acetyl-NAC 2.2 ND ND Yeh et al. 2004
Ala-NAC 1.8 ND ND
Acetyl-D-Ala-NAC 1.0 ND ND
Acetyl-D-Leu-NAC 5.0 ND ND
D-Phe-NAC 6.8 ND ND
Phe-NAC 5.3 ND ND
Acetyl-Phe-NAC 7.2 ND ND
Leu-NAC 4.0 ND ND
Acetyl-Leu-NAC 23.3 ND ND
D-Phe-PheATE 2500 ND ND
Phe-PheATE 3000 ND ND
TEIIsrf, surfactin cluster of Bacillus subtilis (NRPS) D-Phe-PheATE 3000 ND ND Yeh et al. 2004
Phe-PheATE 2666 ND ND
Acetyl-PCP 1.75 x 106 95 0.9 x 10-3 Schwarzer et al. 2002
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thiesterase in a heterologous system (Kotowska et al. 2002)
resulted in complete loss of coelimycin production (Kotowska
et al. 2014). Such a strong effect of TEII inactivation is typical
of chain terminating enzymes (see below); however, in the
case of ScoT, this is unlikely, as the recombinant protein has
very weak hydrolytic activity toward a 12-carbon chain mim-
icking the polyketide chain as opposed to short acyl residues
(Table 1) (Kotowska et al. 2009, 2014). Polyketide precursor
of coelimycin is probably released by a reductase domain
(Gomez-Escribano et al. 2012).
It is not clear why the removal of editing thioesterases is
detrimental to the efficiency of some megasynthases, and it
apparently does not affect others. For example, deletion of
pikAV gene coding TEII from the picromycin/methymycin
synthase (Pik PKS) of Streptomyces venezuelae had no influ-
ence on the level of polyketide production (Chen et al. 2001).
Table 1 (continued)
RifR, rifamycin cluster of Amycolatopsis
mediterranei (PKS/NRPS)
Decanoyl-CoA 160 ND ND Claxton et al. 2009
Octanoyl-CoA 31 ND ND
Propionyl-CoA 25 ND ND
Butyryl-CoA 13 ND ND
Acetyl-CoA 11 ND ND
Isobutyryl-CoA 9.6 ND ND
Hexanoyl-CoA 5.9 ND ND
Methylmalonyl-CoA 1.8 ND ND
Malonyl-CoA 1.5 ND ND
Propionyl-RifM1 210 ND ND
Acetyl-RifM1 150 ND ND
Methylmalonyl-RifM1 54 ND ND
RedJ, prodiginine cluster of S. coelicolor
A3(2) (PKS/NRPS)
Decanoyl-RedQ 460 138 5.2 Whicher et al. 2011
Decanoyl-AcpP 660 198 5.0
Dodecanoyl-AcpP 3316 498 2.5
Acetyl-AcpP 55 200 60
Malonyl-AcpP − − −
Malonyl-RedQ − − −
Decanoyl-CoA 0.67 3.0 70.0
Dodecanoyl-CoA 2.08 2.0 16.7
Acetyl-CoA 0.02 1.2 1050
Malonyl-CoA − − −
Type II thioesterase Substrate Activity References
TEII, DEBS cluster of Saccharopolyspora
erythraea (PKS)




ScoT, coelimycin cluster of Streptomyces
coelicolor A3(2) (PKS)
Propionyl-p-NP ++ Kotowska et al. 2014
Dodecanoyl-p-NP +
TEIIsrf, surfactin cluster of Bacillus subtilis
(NRPS)










Results of the experiments where kinetic constants were not determined are shown qualitatively in the second part of the table. Symbols and
abbreviations:
++ high activity, + low activity, − no reaction, CoA coenzyme A, NAC N-acetyl cysteamine, ND not determined, p-NP p-nitrophenyl, ACP2 ACP from
module 2 of 6-deoxyerythronolide synthase (DEBS), ACPFAS ACP from the fatty acid synthase, ACPL ACP from the loading module of DEBS, AcpP
ACP from E. coli fatty acid synthase, ATLACPL loading module of DEBS, PCP PCP domain frommodule 2 of tyrocidine synthetase, PheATEmodule 1
of gramicidin synthetase, PikAIIImodule 5 of pikromycin synthase, ProCATmodule 2 of tyrocidine synthetase, RedQ ACP of the prodiginine pathway,
RifM1 module 1 of rifamycin synthase, TycA/ProCAT-LeuCAT hybrid NRPS made of modules 1, 2 and 10 of tyrocidine synthetase
a Analog of the first condensation product with opposite configuration of hydroxyl group
bAnalog of the second condensation product with opposite configuration of methyl group
c (2S,3R)-2-Methyl-3-hydroxypentanoyl-NAC
d 2-Methyl-3-ketopentanoyl-NAC
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However, its coexpression with Pik PKS in a heterologous
host (Streptomyces lividans) resulted in twofold to sevenfold
increase in polyketide production levels (Tang et al. 1999).
Perhaps, its effect in the native host is significant only in
special circumstances other than the conditions of the exper-
iment optimized for antibiotic production. It is noteworthy
that overexpression of pikAV gene in S. venezuelae resulted
in 50–70 % reduction of polyketide production (Kim et al.
2002), which can be explained by removal of correct
substrates from the synthase. PikAV TEII was shown to
hydrolyze malonyl and methylomalonyl chains representing
correct extender units attached to ACP at a similar rate as
acyl groups representing nonreactive residues (Table 1)
(Kim et al. 2002).
Removal of aberrant intermediates
Activity of TylO thioesterase was also tested against a diketide
and triketide residues representing abnormal intermediates of
tylosin biosynthesis (Table 1) (Heathcote et al. 2001). Such
substrates were hydrolyzed with much lower efficiency than
short acyl groups; hence, the conclusion that they are not
significant TEII substrates in vivo. Nevertheless, they can be
hydrolyzed if they remain exposed for a sufficiently long time
(Fig. 1d). Acyltransferase domains recruiting extender units in
PKSs have high specificity; however, as shown by the practice
of combinatorial biosynthesis and modified substrates feed-
ing, the remaining domains, including the terminal
thioesterase, accept a wide range of modified molecules
(McDaniel et al. 1999; Cummings et al. 2014). Therefore,
potentially erroneous intermediates should not be the cause
of blocking the PKS assembly line; they would rather con-
tribute to the formation of by-products.
Although adenylating domains of NRPSs are highly spe-
cific, they occasionally incorporate amino acids that are not
accepted by the condensing domain, which results in stalling
the synthesis process. Therefore, the editing role of TEIIs
appears to include the removal of amino acids and peptides
that block the NRPS, in addition to hydrolysis of acyl groups
arising due to mispriming. TEIIs from surfactin and bacitracin
synthetases hydrolyzed PCP-bound intermediates which
could not be further processed by the NRPS (amino acid and
tripeptide), however, much more slowly than the acetyl group
(Table 1) (Schwarzer et al. 2002). Tioesterase TycF from
Bacillus brevis showed no activity on the correct intermediates
of tyrocidine synthesis (two to five amino acid chains), but
individual amino acids were hydrolyzed with a yield compa-
rable to that of the acetyl group (Table 1) (Yeh et al. 2004).
Control of starter units
Propionate is the correct starter unit for 6-deoxyerythronolide
B (6dEB) synthesis—the erythromycin precursor
produced by the most investigated modular type I PKS
—DEBS of Saccharopolyspora erythraea. Inactivation of
the gene encoding the TEII caused a significant admixture
of 15-norerytromycin, which is a derivative of 15-nor-
6dEB resulting from the incorporation of acetate instead
of propionate as a starter unit. There was no significant
decrease in the total production of polyketides, it
remained at 80 % of the normal level (Hu et al. 2003).
An experiment was conducted on the DEBS TEII activity
against acetyl, propionyl, and butyryl residues attached to
isolated ACP domains from the DEBS loading module
(ACPL) and from module 2 of DEBS (ACP2). TEII was
active only against the acetyl group bound to ACPL
(Table 1) (Hu et al. 2003). This led to the conclusion that
the TEII is involved in the control of the starter unit by
the loading module (Fig. 1c).
Brown et al. (1995) observed previously that the major
product of the first subunit of the synthase (DEBS1) expressed
in S. coelicolor A3(2) was the nor-analog derived from
acetate as a starter unit instead of propionate. This can be
explained by the lack of the TEII selectively removing acetate
from ACPL and potentially by strong preference for propio-
nate of TEII ScoT from S. coelicolor Cpk PKS (Kotowska
et al. 2009).
When DEBS genes were expressed in S. lividans and
S. coelicolor A3(2), it was observed that coexpression of
TEII significantly reduced the content of 15-nor-6dEB
and also caused a twofold increase of concentration of
products (Hu et al. 2003). Similarly, upon coexpression
of DEBS genes with TEII in E. coli, the production of
6dEB has doubled. Interestingly, in E. coli, no 15-nor-
6dEB was detected even in the absence of TEII (Pfeifer
et al. 2002; Hu et al. 2003). In experiments, in which
improper acylation of ACPL of DEBS was avoided by
inactivation of ketosynthase domain of module 1 and
feeding to the culture of a correct diketide accepted
directly by module 2, addition of TEII also increased
twice the level of produced polyketide (Hu et al. 2003).
This indicates that the positive effect of TEII on DEBS
performance is not restricted to the control of the starter
unit.
Other examples of starter unit control by TEIIs come
from nonmodular PKSs. Type II PKS systems producing
nonacetate-primed polyketides include proteins homolo-
gous to FabD (malonyl-ACP/CoA transferase) which
were first postulated to load the unusual starters on
the corresponding ACPs. It was found later that those
FabD homologues, such as ZhuC from R1128 PKS
(Tang et al. 2004), EncL from enterocin PKS
(Kalaitzis et al. 2011), and presumably DpsD from
daunorubicin PKS (Castaldo et al. 2008), are in fact
thioesterases which facilitate priming of ACP with the
correct starter units (butyrate, benzoate, and propionate,
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respectively) by hydrolyzing “unwanted” acetyl residues
(Fig. 1c).
TEII AsuC15 from asukamycin biosynthetic cluster
also influences the starter unit selection for polyketide
chain, but in a different manner—maintaining balance
between different compounds and preventing any of
them from becoming dominant. Asukamycin, a mixture
of related antimicrobial and potential antitumor com-
pounds isolated from Streptomyces nodosus subsp.
asukaensis, is built from two triene chains with unusual
starter units assembled by type II and III PKSs (Rui
et al. 2010). So-called lower polyketide chain starts with
3-amino-4-hydroxybenzoic acid which then becomes a
core structure common to all asukamycins. The upper
chain starts with residues which are also substrates
for FAS: cyclohexylcarbonyl-CoA (CHC-CoA) in
asukamycin A1 and branched acyl-CoA in related com-
pounds. Besides, CHC-CoA is a precursor of
ω-cyclohexyl fatty acids which account for 3.1 % of total
cellular fatty acids, and branched chains are predominantly
used for fatty acid synthesis in Streptomyces.
AsuC15 can remove the CHC-acyl intermediate from
AsuC5-ACP to enhance the production of branched
starter-derived compounds, as the asuC15 mutant pre-
dominantly accumulates asukamycin A1 rather than an
equal amount of all the variants observed in the wild-
type strain. AsuC15 thioesterase is also proposed to
suppress excess ω-cyclohexyl fatty acid formation and
help to maintain membrane homeostasis by releasing the
CHC residue from FAS ACP, as the percentage of
ω-cyclohexyl fatty acids was increased fivefold in the
asuC15 mutant (Rui et al. 2010). The double role of
AsuC15 TEII is an interesting example of primary and
secondary metabolism interconnection.
Providing key intermediates
Another role for TEIIs found in secondary metabolite
biosynthetic complexes is the release of pathway interme-
diates from a carrier domain allowing them to be further
processed by subsequent proteins (Fig. 1e). This can be
exemplified by the synthesis of kutznerides, a mixture of
nine antimicrobial cyclic hexadepsipeptides containing 2-
(1-methylcyclopropyl)-d-glycine (MecPGly), isolated
from the soil actinomycete Kutzneria sp. 744 (Fujimori
et al. 2007). The kutzneride cluster encodes three
multidomain proteins, which make up six NRPS modules
and four stand-alone proteins: KtzB and KtzN which are
homologous to adenylation domains, KtzC homologous to
a thiolation domain (PCP) and KtzF—a TEII. The KtzB,
N, and C proteins are proposed to form a “module”
synthesizing the MecPGly moiety, which is then released
by KtzF thioesterase and loaded on the next NRPS
protein.
In nikkomycin antibiotics biosynthesis, the β-hydroxy-
His is released from the didomain NRPS NikP1 by a TEII
NikP2 and is further transformed to the imidazolone base
found in nikkomycins X/I (Chen et al. 2002). When
NikP2 was disrupted in Streptomyces tendae Tü901, the
mutant strain failed to produce nikkomycins X/I. The
disruption did not affect production of nikkomycins Z/J
in which the imidazolone base is replaced by uracil base
(Lauer et al. 2001). A similar thioesterase Bph from
Amycolatopsis balhimycina releases from a carrier protein
β-hydroxy-Tyr—a nonproteinogenic amino acid which is
incorporated into the backbone of a glycopeptide antibi-
otic balhimycin (Mulyani et al. 2010). Inactivation of Bph
resulted in complete block of balhimycin synthesis which
could be restored by addition of free β-hydroxy-Tyr (Puk
et al. 2002).
Prodiginines are a class of bioactive products of
S. coelicolor A3(2) which are synthesized by a hybrid PKS/
NRPS system (red gene cluster). Products of red genes act in
concert with the primary metabolism enzymes from fatty acid
synthesis which assemble a dodecanoyl chain attached by a
thioester bond to RedQ (ACP protein coded within the red
cluster). The TEII RedJ was shown to facilitate transfer of the
dodecanoyl group from RedQ onto a multidomain protein
RedL which performs further elongation (Whicher et al.
2011). Deletion of RedJ gene leads to a 75 % decrease in
prodiginine production. Biochemical studies of enzymatic
activity of RedJ proteins showed its strong preference for
dodecanoyl residue over short chains and selectivity toward
RedQ over FAS ACP (Whicher et al. 2011).
Releasing products
Polyether ionophore antibiotics such as monensin,
nanchangmycin, and nigericin are synthesized by modular
PKSs which lack terminal TE domains (Liu et al. 2009). The
polyunsaturated polyketide chain undergoes a cascade of ox-
idative cyclizations being still attached to the ACP, as opposed
to classic macrolide polyketides which are released by a TEI
domain and then are subject to post-polyketide modifications.
It was shown recently that the intermediate polyketide chain is
transferred from the modular PKS to a discrete ACP protein
which serves as a carrier for further steps of polyether forma-
tion (Harvey et al. 2007). The final product is then hydrolyzed
by a TEII (Fig. 1e).
Monensin and nanchangmycin are released by TEIIs
which were originally assigned as epoxide hydrolases:
MonCII and NanE, respectively (Harvey et al. 2006; Liu
et al. 2006, 2008). NigCII is proposed to play a similar role
in nigericin biosynthesis, based on its more than 50 %
sequence similarity to NanE and MonCII. Deletion of
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monCII and nanE genes resulted in complete inhibition of
respective polyketides production (Oliynyk et al. 2003; Liu
et al. 2006). Recombinant MonCII and NanE proteins pref-
erentially hydrolyzed NAC derivatives of monensin and
nanchangmycin, respectively, over substrates representing
intermediates of earlier steps of biosynthesis (Harvey et al.
2006; Liu et al. 2006, 2008). Monensin PKS cluster of
Streptomyces cinnamonensis contains two other genes cod-
ing TEIIs, namelymonAIX andmonAXwhich are postulated
to have an editing role. In concordance with that, deletion of
these genes caused only a modest drop in monensin yield,
and MonAIX was found to efficiently hydrolyze acetate
residue (Harvey et al. 2006).
An experiment, which demonstrated the importance of a
TEII for a hybrid PKS/NRPS efficiency, was the inactivation
of the TEII gene from Streptomyces lydicus AS 4.2501,
resulting in an almost complete loss of production of RNA
polymerase inhibitor streptolydigin (Yu et al. 2006). Its close
homologue SlgB from S. lydicus NRRL2433 was hypothe-
sized to have an editing role (Olano et al. 2009b).
Streptolydigin biosynthesis pathway was deciphered (Olano
et al. 2009b; Gómez et al. 2012), but the authors did not
propose the mode of product release fromPKS/NRPS proteins
(all multienzymes lacking the thioesterase or reductase
domains). In our opinion, TEII is a likely candidate for a
chain-releasing enzyme in streptolydigin biosynthesis.
Fungal type I iterative highly reducing PKSs are accompa-
nied by TEIIs which release polyketide chains of desired
length (Xu et al. 2013; Zabala et al. 2014). LovG TEII from
lovastatin biosynthetic cluster of Aspergillus terreus was
shown to release dihydromonacolin L acid from PKS protein
and also play a role in removal of aberrant intermediates.
Disruption of lovG gene dramatically decreased lovastatin
production by A. terreus. Interestingly, a small amount (less
than 5 %) was still produced, since LovG could be replaced,
with much smaller efficiency, by an endogenous A. terreus
thioesterase (Xu et al. 2013). In a detailed study on brefeldin A
biosynthesis, Zabala et al. (2014) have shown recently that a
TEII (Bref-TH thiohydrolase) from Eupenicillium
brefeldianum ATCC 58665 releases an octaketide product
from Bref-PKS leading to brefeldin A. Bref-PKS alone syn-
thesized in vitro longer products (nonaketides) which could
be released by base hydrolysis. Chain length control by the
releasing enzyme was also observed in fumagillin pathway by
Zabala et al. (2014).
Importance of TEIIs in synthetic biology approach
to PKS- and NRPS-derived biosynthetic systems
Although constructing biological systems for production of
novel biologically active compounds with designed chem-
ical structures has become a reality, it is far from being
applicable on an industrial scale. Modular multienzymes
such as PKSs and NRPSs, including those known only from
sequence analysis, offer a broad choice of potential parts
“building bricks” to construct machineries to assemble
unnatural secondary metabolites. Realization of this con-
cept encounters a number of obstacles beginning with a
shortage of ideas for really new chemical structures which
could become better drugs. Therefore, analogs of existing
compounds are usually tested.
Other aspects which need to be taken into account are the
availability of precursors in the chosen host organism, sub-
strate selectivity of chain assembling units, and compatibility
of the parts of the machinery. Intermediates must be accepted
by downstream domains/enzymes, including those responsi-
ble for chain release and further modifications such as glyco-
sylation, methylation, and halogenation (Cummings et al.
2014; Poust et al. 2014).
As shown in the current review, overall performance of
many megasynthases strongly depends on the presence of
TEIIs. It is straighforward that TEIIs responsible for inter-
mediate or product release are indispensable. It is not clear
why some megasynthases must be accompanied by editing
thioesterases, while others are not affected by TEII inactiva-
tion. One might speculate that variations in the ratio of free
versus acylated CoA in the cell and in the specificity of 4′PP
transferases may be responsible for differences in the fre-
quency of ACP (PCP) mispriming. In some PKS and NRPS
clusters, no TEII genes were identified, and in others, mul-
tiple TEII genes were found, where they probably have their
specialized functions. In general, coexpression of native or
heterologous TEIIs increased the level of production of final
compounds. However, an adverse effect of excess of a TEII
due to correct substrates removal has also been reported
(Kim et al. 2002).
We suggest that inclusion of an appropriate TEII should
be carefully considered when designing an artificial system
built from PKS and NRPS parts. The features to analyze
should include substrate specificity (in terms of both acyl or
peptide residues and carrier domains) and the rate of hydro-
lysis. Potentially, TEIIs may be used to influence the starter
unit selection. Chain length control by a discrete releasing
enzyme appears to be a common feature of highly reducing
iterative PKSs and could be exploited for generation of new
compounds. In addition, it is possible that the activity of
host TEIIs may interfere with the heterologous system under
study.
Two models of action of TEIIs have been proposed
(Heathcote et al. 2001; Claxton et al. 2009). In high specificity
model, a TEII recognizes and hydrolyzes only aberrant resi-
dues, while in low specificity model, a TEII hydrolyzes with
low rate both correct extender units and incorrect residues.
Correct extender units are quickly processed by the PKS
(NRPS), while residues stalling the ACP (PCP) domain for a
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sufficiently long time are removed even by a slow enzyme
with low specificity. Currently, it is not possible to predict in
detail the specificity of TEIIs on the basis of sequence analy-
sis, and they must be studied experimentally case by case.
Structural data are available for three TEIIs: RifR from
rifamycin hybrid PKS/NRPS (Claxton et al. 2009), RedJ from
prodiginine hybrid PKS/NRPS (Whicher et al. 2011), and SrfD
from surfactin NRPS (Koglin et al. 2008). It was found that
TEIIs can have several conformations, and their conformational
changes enable interactions with multienzyme domains. They
possess flexible lid structures which change the size and shape
of the active site chamber and control the access of substrates.
For detailed discussions on the implications for substrate
accommodation by TEIIs and comparison with TEI structures,
see the comprehensive experimental articles cited above.
A new classification of all thioesterases has been proposed
based on comparison of primary and tertiary structures and is
available in a continuously updated database, ThYme
(Thioester-active enzYmes, http://www.enzyme.cbirc.iastate.
edu) that covers also other enzyme groups taking part in fatty
acid synthesis (Cantu et al. 2010). According to this classifi-
cation, TEIIs reviewed in this work belong to the family TE18
and thioesterase domains of PKSs, and NRPSs belong to the
families TE16 (which includes also FAS TE domains) and
TE17. A common feature of all three of them is the α/β
hydrolase fold. There is also a small family TE15 which
comprises a few hotdog fold thioesterases involved in poly-
ketide synthesis. The role of two of them as chain terminating
enzymes in enedyine synthesis was shown experimentally
(Kotaka et al. 2009; Liew et al. 2010).
From the large number of identified TEIIs, only a few have
been characterized in detail. In our opinion, these enzymes are
worth further investigation, and their inclusion in a set of
biobricks designed to build new biosyntheticmachineries involv-
ing PKS/NRPS parts will be helpful in fine tuning of the systems.
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